Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova

V. Crudu, E. Romancenco, E. Noroc, N. Turcan, G. Blagodeteleva (Chisinau, Republic Of Moldova)

Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Session: Tuberculosis and latent tuberculosis infection in subpopulations
Session type: Poster Discussion
Number: 1616
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Crudu, E. Romancenco, E. Noroc, N. Turcan, G. Blagodeteleva (Chisinau, Republic Of Moldova). Multidrug-resistant and extensively drug resistance tuberculosis has a strong public health and economical impact in the Republic of Moldova. Eur Respir J 2013; 42: Suppl. 57, 1616

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence and trend of ofloxacin-resistance among MDR-TB including XDR-TB cases in Ukraine
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Trend in TB control in Republic of Moldova: High MDRTB burden country
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Estimating costs for treating patients with multi-drug resistant tuberculosis (MDR TB) under the regional tuberculosis control program, Tomsk (Russia)
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015

MDR TB treatment results of GFATM program implementation in Tomsk, Russia
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Rifampicin-resistant tuberculosis (RR-TB) in eastern Europe
Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments
Year: 2016


The health economics of treating MDR-TB in the Indian private sector
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016


Prevalence of fluoroquinolon-resistance among different MDR tuberculosis cases in Ukraine
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013


Nationwide anti-tuberculosis drug resistance survey in the Republic of Azerbaijan
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014


Implementation of rapid drug-susceptibility testing for patients at high risk of multidrug-resistant tuberculosis in Cambodia
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013

High prevalence of hepatitis C among patients with drug-resistant tuberculosis and its impact on the treatment outcome in Azerbaijan prisons
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Current status of fluoroquinolone use for treatment of tuberculosis in Korea
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Changing prevalence of MDR TB and XDR TB in a tertiary care hospital in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Social determinants of drug-susceptible and drug resistant tuberculosis
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016

Tuberculosis and HIV infection in combination with multidrug resistant MBT on Northwest of Russia
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016

Knowledge and attitude about tuberculosis disease in a health workers population
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013

Out-patient MDR-TB care in Moldova
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015

The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Features of different M.tuberculosis strains that were isolated from MDR-TB patients in Kharkiv, Ukraine
Source: International Congress 2016 – Epidemiological insights into tuberculosis pathogenesis
Year: 2016


Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

Spreading of tuberculosis with extensive drug resistant MBTin Northwest region of Russia
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014